Results

Total Results: 726 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

121. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Njxn2r3qtWKdBf2_VhS2Aw
     April 01, 2016 - secondary prevention trials, 20- year CRC mortality was reduced among persons assigned to as- pirin therapy … Evidence from CVD primary and secondary preven- tion studies suggested that aspirin therapy reduces CRC … Effects of aspirin therapy on total cancer incidence within 10 years of initiation were generally small … Cuzick and colleagues used a modeling approach to conclude that the benefits of initiating therapy with … Diabetes. 1989;38:491-8.

122. Draft Recommendation: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/obstructive-sleep-apnea-adults-screening
     March 29, 2022 - Mandibular advancement devices (MADs) are an alternative therapy to PAP for patients with OSA who prefer … . 4 Surgical interventions for OSA are available, but they generally are not considered first-line treatments … Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. … Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce … Neck grasp predicts obstructive sleep apnea in type 2 diabetes mellitus.

123. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
     February 18, 2020 - , presence of diabetes, and smoking status as risk factors. … vs no treatment, or delayed vs earlier treatment in adults in this age group. … or treatment-to-target strategies affect clinical out- comes is extremely limited. … to “which population should be prescribed statin therapy?” … Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from

124. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/XCAMvXugbjnYnGmeF5GtUS
     April 13, 2021 - Diabetes. 2011;60(11):2748-2757. doi:10. 2337/db11-0650 26. … Diabetes Care. 2008;31(4):701-707. doi:10.2337/dc07-1829 32. … Vitamin D supplementation and prevention of type 2 diabetes. … Diabetes Obes Metab. 2017;19(1):133-141. doi:10.1111/dom.12794 74. … Diabetes Obes Metab. 2016;18(10):1006-1012. doi:10.1111/dom.12709 80.

125. Archived: Brief Evidence Summary: Peripheral Arterial Disease (PAD): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/peripheral-arterial-disease-pad-screening
     August 08, 2005 - identification of conventional risk factors alone (e.g., through earlier or more aggressive use of treatments … , such as aspirin or other anti-platelet agents, lipid-lowering therapy, blood pressure treatment, or … , such as aspirin or other anti-platelet agents, lipid-lowering therapy, blood pressure treatment, or … Peripheral arterial disease: epidemiology and drug therapy. … Preventive foot care in diabetes. Diabetes Care 2004;27 Suppl 1:S63-S64. 19.

126. Archived: Brief Evidence Summary: Peripheral Arterial Disease (PAD): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/peripheral-arterial-disease-pad-screening-2005
     August 08, 2005 - identification of conventional risk factors alone (e.g., through earlier or more aggressive use of treatments … , such as aspirin or other anti-platelet agents, lipid-lowering therapy, blood pressure treatment, or … , such as aspirin or other anti-platelet agents, lipid-lowering therapy, blood pressure treatment, or … Peripheral arterial disease: epidemiology and drug therapy. … Preventive foot care in diabetes. Diabetes Care 2004;27 Suppl 1:S63-S64. 19.

127. Draft Research Plan: Vitamin D Deficiency in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vitamin-d-deficiency-screening-adults
     October 25, 2018 - Does treatment of vitamin D deficiency with vitamin D result in improved health outcomes?     b. … Does treatment efficacy vary among patient subpopulations at higher risk for vitamin D deficiency (e.g … What are the harms of treatment of vitamin D deficiency with vitamin D?     b. … (e.g., depression, diabetes, chronic kidney disease, infertility, multiple sclerosis) Intervention … Outcomes KQs 1, 3: All-cause mortality Incidence of falls Incidence of fractures Incidence of diabetes

128. Draft Recommendation: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
     April 19, 2022 - Food and Drug Administration in menopausal persons are limited to the treatment of menopausal symptoms … for the treatment of menopausal symptoms (e.g., vasomotor hot flashes or vulvovaginal symptoms) or for … have reported on the risk of breast cancer as one of the primary adverse outcomes of treatment. … Two trials reported on the effects of menopausal hormone therapy on incident diabetes. … or for the prevention of osteoporosis, if alternative therapies are not tolerated, based on a careful

129. Carol M. Mangione, M.D., M.S.P.H. | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/carol-m-mangione-md-msph
     March 01, 2022 - Mangione’s areas of expertise include diabetes, diabetes prevention, preventive care, health disparities … Mangione was the principal investigator for “The Diabetes Health Plan: A System-Level Intervention to … Prevent and Treat Diabetes,” funded by the Centers for Disease Control and Prevention (CDC) and the … Mangione is the director of the “UCMyRx Medication Therapy Management Program,” which embeds clinical … a shared decision making tool to help patients with prediabetes learn about the condition and make treatment

130. Screening for Coronary Heart Disease: Clinician Fact Sheet (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cAs__BR8J4rgcZ4vQgfaTx
     April 01, 2009 - than later treatment. … This means that good studies have shown that early treatment, compared with later treatment, helps patients … diagnostic evaluations, and may be subjected to overtreatment with medical/and or invasive surgical therapies … y Control diabetes, hypertension, and dyslipidemia, if present. … y Consider aspirin therapy for men at increased CHD risk.

131. Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication
     August 23, 2022 - underprediction in disadvantaged communities 10 , 11 that could lead to underutilization of preventive therapies … vs fixed-dose treatment strategies. … Definitively determining whether statin therapy is associated with increased risk of diabetes in primary … Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from … Statin therapy: diabetes mellitus risk and cardiovascular benefit in primary prevention.

132. The Ankle–Brachial Index for PAD and CVD Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_Fp-7sDqohFNj_9WF3_tY
     September 01, 2013 - Clinicians may be reluctant to withhold therapy on the basis of lower risk estimates (for example, men … at high CAD risk with a normal ABI reclas- sified as intermediate risk) but might add therapy on the … Interventions (for example, antiplatelet therapy, statins, or angiotensin-converting enzyme inhibitors … However, many persons with PAD who were included in major CVD treatment trials had comorbid CAD, diabetes … , or both and should therefore already be receiving therapies for CVD risk reduction (38–43).

133. Draft Recommendation: Vitamin D Deficiency in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/vitamin-d-deficiency-screening-adults
     September 22, 2020 - have been associated with risk for fractures, falls, functional limitations, some types of cancer, diabetes … 31.2 ng/mL) on a variety of health outcomes, including all-cause mortality, fractures, incidence of diabetes … A pooled analysis of the five trials (n=3,356) found no difference in the incidence of diabetes among … Lancet Diabetes Endocrinol . 2017;5(12):986-1004. 4. Ross AC, Manson JE, Abrams SA, et al. … Vitamin D 20,000 IU per week for five years does not prevent progression from prediabetes to diabetes

134. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index
     September 03, 2013 - Clinicians may be reluctant to withhold therapy on the basis of lower risk estimates (for example, men … at high CAD risk with a normal ABI reclassified as intermediate risk) but might add therapy on the basis … Interventions (for example, antiplatelet therapy, statins, or angiotensin-converting enzyme inhibitors … However, many persons with PAD who were included in major CVD treatment trials had comorbid CAD, diabetes … , or both and should therefore already be receiving therapies for CVD risk reduction 38-43 .

135. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index-2013
     September 03, 2013 - Clinicians may be reluctant to withhold therapy on the basis of lower risk estimates (for example, men … at high CAD risk with a normal ABI reclassified as intermediate risk) but might add therapy on the basis … Interventions (for example, antiplatelet therapy, statins, or angiotensin-converting enzyme inhibitors … However, many persons with PAD who were included in major CVD treatment trials had comorbid CAD, diabetes … , or both and should therefore already be receiving therapies for CVD risk reduction 38-43 .

136. Final Research Plan: Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/peripheral-artery-disease-in-adults-screening-with-the-ankle-brachial-index
     June 16, 2016 - will be examined based on the following factors: age (particularly ≥65 years), sex, race/ethnicity, diabetes … interventions primarily aimed at CVD reduction: interventions for smoking cessation, cholesterol-lowering therapy … , diet and exercise (with or without weight loss), blood pressure control, and antiplatelet therapy … Exercise or physical therapy interventions aimed at improving lower limb function Vitamins … subpopulations at greater risk for PAD based on age (particularly ≥65 years), sex, race/ethnicity, diabetes

137. Screening for Dyslipidemia in Younger Adults: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SaASReVeD_fpHZQbeBZD5s
     October 01, 2016 - Regarding treatment, both drug therapy and lifestyle interventions (such as exercise and diet changes … National Diabetes Education Initiative. … Diabetes management guidelines: American Diabetes Association (ADA) 2016 guidelines. 2013. … Exercise Therapy/ 20. … interventions Drug (e.g., statins) and lifestyle interventions (e.g., exercise and diet changes) Other types of treatments

138. Archived: Peripheral Arterial Disease: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/peripheral-arterial-disease-screening-1996
     January 01, 1996 - quality of life. 1 , 5 Persons at increased risk for PAD include cigarette smokers and persons with diabetes … There has been no research to examine whether the detection and treatment of asymptomatic persons with … A recent international workshop sponsored by the American Diabetes Association and American Heart Association … recommends annual screening for PAD in patients with diabetes. 16   Return to Table of Contents … Assessment of peripheral vascular disease in diabetes.

139. Twelfth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/twelfth-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services
     January 01, 2022 - Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents Address the effects of … lifestyle interventions, pharmacotherapy, or both for treatment of screen-detected prediabetes and diabetes … Screening for Prediabetes and Type 2 Diabetes in Adults Evaluate data on the effects of lifestyle … interventions and medical treatments for screen-detected prediabetes and diabetes on health outcomes … over a longer followup period, particularly in populations that have a higher prevalence of diabetes

140. Archived: Evidence Summary: Obesity in Adults: Screening and Counseling, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
     December 15, 2003 - Force (USPSTF) recommended periodic height and weight measurement. 7 Increased obesity prevalence, therapeutic … Discussion Efficacy of Therapeutic … All obesity therapies carry promise and burden, which must be balanced in clinical decisionmaking. … Role of orlistat in the treatment of obese patients with type 2 diabetes. … An operation proves to be the most effective therapy for adult-onset diabetes mellitus.